Assessment of NMYC amplification: A comparison of FISH, quantitative PCR monoplexing and traditional blotting methods used with formalin-fixed, paraffin-embedded neuroblastomas

Analytical and Quantitative Cytology and Histology

Volumn 27, Issue 1, 2005, Pages 5-14

  Layfield, Lester J ^a,c   Willmore Payne, Carlynn ^a   Shimada, Hiroyuki ^b   Holden, Joseph A ^a  

^a ARUP LABORATORIES   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Gene amplification; Hybridization in situ, fluorescence; Neuroblastoma; NMYC; Polymerase chain reaction

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ACCURACY; ARTICLE; CHILD; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NEUROBLASTOMA; ONCOGENE C MYB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; TISSUE SECTION;

BLOTTING, SOUTHERN; CELL LINE, TUMOR; CHILD; FEMALE; FORMALDEHYDE; GENE AMPLIFICATION; GENES, MYC; GENETIC TECHNIQUES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEUROBLASTOMA; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PROKARYOTIC INITIATION FACTOR-2; TISSUE FIXATION;

MONOPLEX;

EID: 14344263630     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi W, Roald B: Terminology and morphologic criteria of neuroblastic tumors. Cancer 1999;86:349-363
2. Shimada H, Chattern J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-416
3. Seeger RC, Brodeur GM, Sather H, Salton A, Siegel S, Wong KY, Hammond D: Association of multiple copies of the NMYC oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-1116
4. Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M: Prognostic significance of MYC N oncogene expression in childhood neuroblastoma. J Clin Oncol 1998;16:3286-3294
5. Crabbe DCG, Peters J, Seeger RC. Rapid detection of MYC N gene amplification in neuroblastoma using polymerase chain reaction. Diagn Mol Pathol 1992;1:229-234
6. Sartelet H, Grossi L, Pasquier D, Combaret V, Bouvier R, Ranchere D, Plantaz D, Munzer M, Philip T, Birembaut P, Zahm JM, Bergeron C, Gaillard D, Pasquier B: Detection of NMYC amplification by FISH in immature areas of fixed neuroblastomas: More efficient than Southern blot/PCR. J Pathol 2002;198:83-91
7. Bar-Am I, Mor O, Yeger H, Shiloh Y, Avivi I: Detection of amplified DNA sequences in human tumor cell lines by fluorescence in situ hybridization. Genes Chromosomes Cancer 1992;4:314-320
8. Shapiro D, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, Look AT: Detection of NMYC gene amplification by fluorescence in situ hybridization. Am J Pathol 1993;142:1339-1349
9. Livingstone A, Mairs RJ, Russell J, O'Donoghue J, Gaze MN, Wheldon TE: N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment. Eur J Cancer 1994;30A:382-389
10. Melegh Z, Balint I, Toth E, Csernak E, Szentirmay Z, Nagy K: Detection of N-myc gene amplification in neuroblastoma by comparative in situ, and real-time polymerase chain reaction. Pediatr Pathol Mol Med 2003;22:213-222
11. Tajiri T, Tanaka S, Shono K, Kinoshita Y, Fujii Y, Suita S, Ihara K, Hara T: Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma. Cancer Lett 2001;166:89-94